In A-fib patients selected using established dose-reduction criteria, the 2.5-mg twice daily dose of apixaban (Eliquis; Bristol-Myers Squibb) provides protection against stroke and death versus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback